Bankruptcy Sale: USBC Southern District of Ohio. Petition No: 25-52140 | In re: AmplifyBio, LLC Bid Deadline: August 15, 2025 by 12:00 PM EST This world-class research and development facility – owned and formerly occupied by AmplifyBio – is a purpose-built facility for preclinical CRO (Contract Research Organization) services. Designed to support pharmaceutical, biotechnology and medical device development, the facility is focused on toxicology, safety, pharmacology and bioanalytic characterization to advance therapeutic innovation. With integrated, specialized laboratories, the property is ideally suited for companies seeking a turnkey solution for regulated, high-complexity research. The property features a highly secured entrance, ensuring enhanced privacy for sensitive research. With its sophisticated infrastructure and comprehensive capabilities, this facility represents a rare opportunity to acquire a premier building tailored to the evolving needs of modern biomedical and clinical research.